Alex Haro - 16 Dec 2025 Form 4 Insider Report for Life360, Inc. (LIF)

Reporting relationship: Director
Issuer ticker: LIF
Reported as of: 16 Dec 2025
Net transaction value: -$120,691
SEC form: 4
Accepted by SEC: 18 Dec 2025, 20:32:31 UTC
Prior SEC filing: 01 Dec 2025
Next SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jay Sood, as Attorney-in-Fact

Key filing fact

Alex Haro filed Form 4 for Life360, Inc. (LIF) on 18 Dec 2025.

Key facts

This page summarizes Alex Haro's Form 4 filing for Life360, Inc. (LIF).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Dec 2025, 20:32.

Change

Previous filing in this sequence was filed on 01 Dec 2025.
Current net transaction value: -$120,691.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001932626 Primary reporting owner

Haro Alex

Relationship: Director
Address: C/O LIFE360, INC., 1900 SOUTH NORFOLK STREET, SUITE 310, SAN MATEO
Signature: /s/ Jay Sood, as Attorney-in-Fact
Signature date: 18 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LIF transaction

Common Stock

Sale

Transaction value: $74,129
Shares: -1,165
Change %: -62%
Price: $63.63
Shares after: 722
Date: 16 Dec 2025
Ownership: Held by ICCA Labs, LLC
Footnotes: F1, F2

LIF transaction

Common Stock

Sale

Transaction value: $46,562
Shares: -722
Change %: -100%
Price: $64.49
Shares after: 0
Date: 16 Dec 2025
Ownership: Held by ICCA Labs, LLC
Footnotes: F2, F3

LIF holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 861,315
Date: 16 Dec 2025
Ownership: Direct
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Footnote F2

The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.

Footnote F3

The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Footnote F4

Includes 1,357 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.